+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 24Weeks - 30Weeks
All Genders
Healthy Volunteers
ID07222722

Near-Infrared Spectroscopy NIRS Monitoring to Detect Acute Kidney Injury in Premature Infants Under 30 Weeks Gestation

Led by NYU Langone Health · Updated on 2026-10-22

100

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the use of near-infrared spectroscopy NIRS to monitor kidney tissue oxygen levels in premature infants born before 30 weeks of gestation. The study aims to describe oxygen saturation patterns and evaluate prenatal and postnatal risk factors for acute kidney injury AKI in these vulnerable newborns. Researchers will also compare rates of complications such as death, length of hospital stay, and duration of mechanical ventilation. Participants will receive non-invasive renal NIRS monitoring using sensors placed within 24 hours of admission to the neonatal intensive care unit NICU. This device uses near-infrared light to measure oxygen saturation in kidney tissues. All enrolled infants will undergo this monitoring during their NICU stay. Throughout the study, researchers will collect data including average NIRS oxygen saturation values up to day 7 of life, serum creatinine levels on specified days, urine output, length of NICU stay, and duration of respiratory support. These measurements will help assess kidney function and complications. The study will continue until NICU discharge, which varies by infant, with total participation lasting approximately one week.

CONDITIONS

Brief Title

NIRS Monitoring in the NICU and AKI

Research Team

S

Sourabh Verma, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here